Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience

• Dai Chihara,
• Luuk Gras,
• Nienke Zinger,
• Nicolaus Kröger,
• Jiri Mayer,
• Jakob Passweg,
• Régis Peffault de Latour,
• Jenny Byrne,
• William Krüger,
• Jan-Paul Bohn,
• Uwe Platzbecker,
• Igor Wolfgang Blau,
• Francesca Bonifazi,
• Grzegorz Helbig,
• Andrew McDonald,
• Martin Mistrik,
• Mohamad Mohty,
• Ron Ram,
• Jaime Sanz,
• Carlos Vallejo Llamas,
• Robert J. Kreitman,
• Patrick J. Hayden,
• Donal McLornan,
• Olivier Tournilhac,
• Michel van Gelder,
• Ibrahim Yakoub-Agha

Affiliations

Dai Chihara

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Luuk Gras

EBMT Statistical Unit

Nienke Zinger

EBMT Study Unit, Leiden

Nicolaus Kröger

University Hospital Eppendorf, Hamburg

Jiri Mayer

University Hospital Brno, Brno, Czech Republic

Jakob Passweg

University Hospital | Basel, Basel

Régis Peffault de Latour

Hopital St. Louis 207, Paris

Jenny Byrne

Nottingham University, Nottingham

William Krüger

Klinik fuer Innere Medizin C, Greifswald

Jan-Paul Bohn

University Hospital Innsbruck, Innsbruck

Uwe Platzbecker

Medical Clinic and Policinic 1, Leipzig

Igor Wolfgang Blau

Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin

Francesca Bonifazi

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna Italy

Grzegorz Helbig

Silesian Medical University, Katowice

Andrew McDonald

Alberts Cellular Therapy, Netcare Pretoria east Hospital, Pretoria

Martin Mistrik

University Hospital, Bratislava, Slovak Republic

Mohamad Mohty

Sorbonne University, Saint-Antoine Hospital, AP-HP, and INSERM UMRs 938, Paris

Ron Ram

Tel Aviv Sourasky Medical Center and Soursky Faculy of Medicine, Aviv

Jaime Sanz

University Hospital La Fe, Valencia

Carlos Vallejo Llamas

Hospital Universitario Donostia, S Sebastian

Robert J. Kreitman

Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Patrick J. Hayden

Department of Haematology, Trinity College Dublin, St. James’s Hospital, Dublin, Ireland

Donal McLornan

University College London Hospitals NHS Trust, London

Olivier Tournilhac

Department of Hematology and Cell Therapy, CHU Estaing, Université Clermont Auvergne, Clermont-Ferrand

Michel van Gelder

University Hospital Maastricht, Maastricht, Netherlands

Ibrahim Yakoub-Agha

CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille